Vertex Pharmaceuticals Inc / Ma
2019 Q4 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 7,850,544 | 1.4% | 17,316,344 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 6,482,978 | 1.2% | 16,553,281 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 7,171,364 | 1.4% | 16,108,291 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 7,047,591 | 1.5% | 14,536,344 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 4,199,713 | 0.9% | 10,428,951 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 4,186,729 | 0.9% | 9,002,205 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 4,002,584 | 0.9% | 8,539,339 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 2,401,000 | 0.5% | 5,743,882 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,451,647 | 0.4% | 3,567,664 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 1,172,782 | 0.3% | 3,372,584 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,077,434 | 0.3% | 3,061,676 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 255,174 | 0.1% | 809,895 | 3/31/2023 |
| 2020 Q3 | 11/13/2020 | 340 | 0.1% | 1,250,658 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 363 | 0.1% | 1,250,659 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 298 | 0.1% | 1,250,664 | 3/31/2020 |
| 2019 Q4 | 2/18/2020 | 274 | 0.1% | 1,250,649 | 12/31/2019 |